In the ever-evolving landscape of aesthetic medicine, a new player has emerged, promising to revolutionize the way we approach wrinkle reduction and facial rejuvenation. Daxxify,
Crown Laboratories has announced a buyout of Revance Therapeutics for $924 million, marking a significant merger in the aesthetics and skincare industry. This deal involves